Genolution제놀루션
225220 · KOSDAQ · ₩225220 · 제놀루션
₩1,717▲ ₩6 (0.35%)End-of-day · Oct 28, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩9.4B | ₩7.1B | ₩9.8B | ₩38B | ₩73B |
| Cost of sales | ₩5.9B | ₩4.8B | ₩5.2B | ₩12B | ₩19B |
| Gross profit | ₩3.5B | ₩2.4B | ₩4.5B | ₩26B | ₩53B |
| Operating income | −₩8.6B | −₩9.2B | −₩7.1B | ₩15B | ₩41B |
| Net income | −₩13B | −₩7.2B | −₩5.6B | ₩15B | ₩34B |
| Net income to shareholders | −₩12B | −₩6.8B | −₩5.5B | ₩15B | ₩34B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩94B | ₩106B | ₩113B | ₩114B | ₩95B |
| Current assets | ₩33B | ₩37B | ₩49B | ₩55B | ₩58B |
| Cash and equivalents | ₩19B | ₩32B | ₩6.1B | ₩7.3B | ₩34B |
| Total liabilities | ₩26B | ₩26B | ₩26B | ₩20B | ₩13B |
| Current liabilities | ₩26B | ₩5.8B | ₩10B | ₩4.6B | ₩13B |
| Borrowings | ₩24B | ₩24B | ₩24B | ₩1.5B | ₩2B |
| Total equity | ₩68B | ₩80B | ₩88B | ₩95B | ₩82B |
| Shareholders' equity | ₩68B | ₩80B | ₩87B | ₩95B | ₩82B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | −₩7B | −₩1.4B | −₩1.1B | ₩14B | ₩26B |
| Capital spending | ₩293M | ₩12B | ₩6.8B | ₩23B | ₩5.1B |
| Free cash flow | −₩7.3B | −₩14B | −₩7.9B | −₩9B | ₩21B |
| Dividends paid | — | — | — | ₩1.8B | ₩5.2B |
Consolidated where available. Amounts in won.
Also known as: Genolution / 제놀루션 / 225220 / KRX:225220
Source: KRX statistical information